Cullin 3 Antikörper (C-Term)
Kurzübersicht für Cullin 3 Antikörper (C-Term) (ABIN2788740)
Target
Alle Cullin 3 (CUL3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Sequenz
- QETDIPEREL VRALQSLACG KPTQRVLTKE PKSKEIENGH IFTVNDQFTS
-
Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 93%, Rabbit: 100%, Rat: 100%, Zebrafish: 100%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against CUL3. It was validated on Western Blot.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the C terminal region of human CUL3
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
-
Kommentare
-
Antigen size: 768 AA
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- Cullin 3 (CUL3)
-
Andere Bezeichnung
- CUL3
-
Hintergrund
-
CUL3 is a component of a ubiquitin E3 ligase that is essential for mitotic division.
Alias Symbols: CUL-3, PHA2E
Protein Interaction Partner: KCTD6, ABTB1, CUL5, DEK, UBE2D1, UBC, RBX1, KEAP1, NCOA3, TNFAIP1, NEDD8, KCTD13, CUL3, SPOP, KLHL3, RHOA, ZMAT4, GMCL1, KLHL12, KCTD9, KLHL2, KLHL22, BTBD2, BTBD1, WDFY4, WDR48, LRRC7, KLHL42, WDR35, LRFN2, WDTC1, TRIM32, NLRP1, DMWD, HIRA, PHIP, PAK1IP1
Protein Size: 768 -
Molekulargewicht
- 84 kDa
-
Gen-ID
- 8452
-
NCBI Accession
- NM_003590, NP_003581
-
UniProt
- Q13618
-
Pathways
- M Phase
Target
-